Have any questions?
+44 1234 567 890
Company Profile
Natama Investment Group Incorporated is a holding company strategically invested and partnered with four companies, all demonstrating exponential growth patterns.
It is trading on the OTC Markets under the ticker symbol AURM.
Natama's singular purpose is to increase its profitability in tandem with that of its loyal shareholders through a diligent and extensive asset selection process based on our superlative in-house combined Market Competence as confirmed by our Executive Board Members' respective profiles.
- Natama is the major shareholder in ProMake Ltd. (promake.com), which designs, develops, and manufactures medical devices utilizing and employing nanotechnology.
Its unique BioPod device can detect COVID, bird flu, diabetes, some cancers, and other diseases.
Microsoft is the exclusive global partner that developed the application to facilitate connecting the device from individuals to medical centers (through the web) by leveraging advanced health data making it a Market Leader in the emerging field of rapid diagnostic devices.
Promake will supply the BioPod devices and distribute them to the respective health service employees and the general public.
Multiple other countries have expressed a very positive interest in the BioPod.
- Natama is the sole owner of Holoxica Healthtech PLC (www.holoxica.com), which exclusively owns four patents enabling 2D data and images to be converted into 3D images and holograms with particular applications in medicine and medical education.
- Natama is the major shareholder in the International American University (IAU) College of Medicine (iau.edu.lc), a full charter institution offering up to PhD and Post-Doctoral degrees.
- Natama is the major investor and partner in Valens Pay Limited (valenspay.com), which offers web and app financial services, including fund transfers, debit cards, and other ancillary financial services.
Valens Pay is registered with FINTRAC.